Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
For how the research on GLP-1s and mood is shaping up more broadly, see our post on GLP-1 medications and mental health
MacDonald PE, El-Kholy W, Riedel MJ, et al
The result of hitting all three receptors simultaneously: Appetite suppressed (GLP-1) Insulin sensitivity improved (GIP) Metabolism actively accelerated (glucagon) It's not just "more of the same" it's a genuinely different mechanism layered on top
Monitoring your response to treatment is an important part of our care
After that, some people were switched to a placebo, while others stayed on tirzepatide for another year
Phase 3 TRIUMPH-1 Trial Results (2026 Update) TRIUMPH-1 is the pivotal Phase 3 obesity trial for retatrutide
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
